Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.

The global Live Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Live Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Vaccines.

Report Scope

The Live Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Live Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Live Vaccines Market Report

Report Metric	Details
Report Name	Live Vaccines Market
CAGR	5%
Segment by Type	Monovalent Live Vaccines Multivalent Live Vaccines
Segment by Application	Adults Children
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, GlaxoSmithKline, Pfizer, Novartis, Astellas Pharma, Emergent BioSolutions, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Live Vaccines Market report?

Ans: The main players in the Live Vaccines Market are Merck, GlaxoSmithKline, Pfizer, Novartis, Astellas Pharma, Emergent BioSolutions, AstraZeneca

What are the Application segmentation covered in the Live Vaccines Market report?

Ans: The Applications covered in the Live Vaccines Market report are Adults, Children

What are the Type segmentation covered in the Live Vaccines Market report?

Ans: The Types covered in the Live Vaccines Market report are Monovalent Live Vaccines, Multivalent Live Vaccines

1 Live Vaccines Market Overview

1.1 Product Overview and Scope of Live Vaccines

1.2 Live Vaccines Segment by Type

1.2.1 Global Live Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Monovalent Live Vaccines

1.2.3 Multivalent Live Vaccines

1.3 Live Vaccines Segment by Application

1.3.1 Global Live Vaccines Market Value by Application: (2024-2030)

1.3.2 Adults

1.3.3 Children

1.4 Global Live Vaccines Market Size Estimates and Forecasts

1.4.1 Global Live Vaccines Revenue 2019-2030

1.4.2 Global Live Vaccines Sales 2019-2030

1.4.3 Global Live Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Live Vaccines Market Competition by Manufacturers

2.1 Global Live Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Live Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global Live Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Live Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Live Vaccines, Product Type & Application

2.7 Live Vaccines Market Competitive Situation and Trends

2.7.1 Live Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Live Vaccines Players Market Share by Revenue

2.7.3 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Live Vaccines Retrospective Market Scenario by Region

3.1 Global Live Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Live Vaccines Global Live Vaccines Sales by Region: 2019-2030

3.2.1 Global Live Vaccines Sales by Region: 2019-2024

3.2.2 Global Live Vaccines Sales by Region: 2025-2030

3.3 Global Live Vaccines Global Live Vaccines Revenue by Region: 2019-2030

3.3.1 Global Live Vaccines Revenue by Region: 2019-2024

3.3.2 Global Live Vaccines Revenue by Region: 2025-2030

3.4 North America Live Vaccines Market Facts & Figures by Country

3.4.1 North America Live Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Live Vaccines Sales by Country (2019-2030)

3.4.3 North America Live Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Live Vaccines Market Facts & Figures by Country

3.5.1 Europe Live Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Live Vaccines Sales by Country (2019-2030)

3.5.3 Europe Live Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Live Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Live Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Live Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific Live Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Live Vaccines Market Facts & Figures by Country

3.7.1 Latin America Live Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Live Vaccines Sales by Country (2019-2030)

3.7.3 Latin America Live Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Live Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Live Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Live Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Live Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Live Vaccines Sales by Type (2019-2030)

4.1.1 Global Live Vaccines Sales by Type (2019-2024)

4.1.2 Global Live Vaccines Sales by Type (2025-2030)

4.1.3 Global Live Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Live Vaccines Revenue by Type (2019-2030)

4.2.1 Global Live Vaccines Revenue by Type (2019-2024)

4.2.2 Global Live Vaccines Revenue by Type (2025-2030)

4.2.3 Global Live Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Live Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Live Vaccines Sales by Application (2019-2030)

5.1.1 Global Live Vaccines Sales by Application (2019-2024)

5.1.2 Global Live Vaccines Sales by Application (2025-2030)

5.1.3 Global Live Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Live Vaccines Revenue by Application (2019-2030)

5.2.1 Global Live Vaccines Revenue by Application (2019-2024)

5.2.2 Global Live Vaccines Revenue by Application (2025-2030)

5.2.3 Global Live Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Live Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Live Vaccines Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Corporation Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GlaxoSmithKline Live Vaccines Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Live Vaccines Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Live Vaccines Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Astellas Pharma

6.5.1 Astellas Pharma Corporation Information

6.5.2 Astellas Pharma Description and Business Overview

6.5.3 Astellas Pharma Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Astellas Pharma Live Vaccines Product Portfolio

6.5.5 Astellas Pharma Recent Developments/Updates

6.6 Emergent BioSolutions

6.6.1 Emergent BioSolutions Corporation Information

6.6.2 Emergent BioSolutions Description and Business Overview

6.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Emergent BioSolutions Live Vaccines Product Portfolio

6.6.5 Emergent BioSolutions Recent Developments/Updates

6.7 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Live Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AstraZeneca Live Vaccines Product Portfolio

6.7.5 AstraZeneca Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Live Vaccines Industry Chain Analysis

7.2 Live Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Live Vaccines Production Mode & Process

7.4 Live Vaccines Sales and Marketing

7.4.1 Live Vaccines Sales Channels

7.4.2 Live Vaccines Distributors

7.5 Live Vaccines Customers

8 Live Vaccines Market Dynamics

8.1 Live Vaccines Industry Trends

8.2 Live Vaccines Market Drivers

8.3 Live Vaccines Market Challenges

8.4 Live Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Astrazeneca plc

List of Tables

Table 1. Global Live Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Live Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Live Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Live Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Live Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Live Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Live Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Live Vaccines Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Live Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Live Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Live Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Live Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Live Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Live Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Live Vaccines Sales by Region (2019-2024) & (K Doses)

Table 18. Global Live Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global Live Vaccines Sales by Region (2025-2030) & (K Doses)

Table 20. Global Live Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global Live Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Live Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global Live Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Live Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America Live Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Live Vaccines Sales by Country (2019-2024) & (K Doses)

Table 27. North America Live Vaccines Sales by Country (2025-2030) & (K Doses)

Table 28. North America Live Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Live Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Live Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Live Vaccines Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Live Vaccines Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Live Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Live Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Live Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Live Vaccines Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Live Vaccines Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Live Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Live Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Live Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Live Vaccines Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Live Vaccines Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Live Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Live Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Live Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Live Vaccines Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Live Vaccines Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Live Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Live Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Live Vaccines Sales (K Doses) by Type (2019-2024)

Table 51. Global Live Vaccines Sales (K Doses) by Type (2025-2030)

Table 52. Global Live Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global Live Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global Live Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Live Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Live Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global Live Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global Live Vaccines Price (USD/Dose) by Type (2019-2024)

Table 59. Global Live Vaccines Price (USD/Dose) by Type (2025-2030)

Table 60. Global Live Vaccines Sales (K Doses) by Application (2019-2024)

Table 61. Global Live Vaccines Sales (K Doses) by Application (2025-2030)

Table 62. Global Live Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global Live Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global Live Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Live Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Live Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global Live Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global Live Vaccines Price (USD/Dose) by Application (2019-2024)

Table 69. Global Live Vaccines Price (USD/Dose) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Merck Live Vaccines Product

Table 74. Merck Recent Developments/Updates

Table 75. GlaxoSmithKline Corporation Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. GlaxoSmithKline Live Vaccines Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Pfizer Live Vaccines Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Novartis Live Vaccines Product

Table 89. Novartis Recent Developments/Updates

Table 90. Astellas Pharma Corporation Information

Table 91. Astellas Pharma Description and Business Overview

Table 92. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Astellas Pharma Live Vaccines Product

Table 94. Astellas Pharma Recent Developments/Updates

Table 95. Emergent BioSolutions Corporation Information

Table 96. Emergent BioSolutions Description and Business Overview

Table 97. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Emergent BioSolutions Live Vaccines Product

Table 99. Emergent BioSolutions Recent Developments/Updates

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. AstraZeneca Live Vaccines Product

Table 104. AstraZeneca Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Live Vaccines Distributors List

Table 108. Live Vaccines Customers List

Table 109. Live Vaccines Market Trends

Table 110. Live Vaccines Market Drivers

Table 111. Live Vaccines Market Challenges

Table 112. Live Vaccines Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Live Vaccines

Figure 2. Global Live Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Live Vaccines Market Share by Type in 2023 & 2030

Figure 4. Monovalent Live Vaccines Product Picture

Figure 5. Multivalent Live Vaccines Product Picture

Figure 6. Global Live Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Live Vaccines Market Share by Application in 2023 & 2030

Figure 8. Adults

Figure 9. Children

Figure 10. Global Live Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Live Vaccines Market Size (2019-2030) & (US$ Million)

Figure 12. Global Live Vaccines Sales (2019-2030) & (K Doses)

Figure 13. Global Live Vaccines Average Price (USD/Dose) & (2019-2030)

Figure 14. Live Vaccines Report Years Considered

Figure 15. Live Vaccines Sales Share by Manufacturers in 2023

Figure 16. Global Live Vaccines Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Live Vaccines Players: Market Share by Revenue in 2023

Figure 18. Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Live Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Live Vaccines Sales Market Share by Country (2019-2030)

Figure 21. North America Live Vaccines Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Live Vaccines Sales Market Share by Country (2019-2030)

Figure 25. Europe Live Vaccines Revenue Market Share by Country (2019-2030)

Figure 26. Germany Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Live Vaccines Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Live Vaccines Revenue Market Share by Region (2019-2030)

Figure 33. China Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Live Vaccines Sales Market Share by Country (2019-2030)

Figure 44. Latin America Live Vaccines Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Live Vaccines Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Live Vaccines Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. U.A.E Live Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Live Vaccines by Type (2019-2030)

Figure 54. Global Revenue Market Share of Live Vaccines by Type (2019-2030)

Figure 55. Global Live Vaccines Price (USD/Dose) by Type (2019-2030)

Figure 56. Global Sales Market Share of Live Vaccines by Application (2019-2030)

Figure 57. Global Revenue Market Share of Live Vaccines by Application (2019-2030)

Figure 58. Global Live Vaccines Price (USD/Dose) by Application (2019-2030)

Figure 59. Live Vaccines Value Chain

Figure 60. Live Vaccines Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Live Attenuated Vaccines for Pets Market Research Report 2025

Global Adult Vaccines Market Research Report 2024

Global Adult and Pediatric Vaccines Market Research Report 2024

Global Biopharmaceutical and Vaccines Market Research Report 2024

Global Seasonal Vaccines Market Research Report 2024

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global Vaccines for the Elderly Market Research Report 2024

Global Live Beneficial Bacteria Market Research Report 2024

Global Poultry Bacterial Disease Vaccines Market Research Report 2024

VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poultry Live Vaccines Market Research Report 2025

Global Live type Poultry Vaccine Market Research Report 2025

Global Multiple Vaccine Market Research Report 2024

Global Consumption Type Vaccine Market Research Report 2024

Global HIV Vaccine Market Research Report 2025

Global Diphtheria Vaccines Market Research Report 2024

Global Live Attenuated Measles Vaccine Market Research Report 2025

Global Vaccination Device Market Research Report 2024

Global Pneumonia Vaccine Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions